[Corrections] Correction to Lancet Oncol 2018; 19: 51–64

Patel MR, Ellerton J, Infante JR, et al. Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial. Lancet Oncol 2018; 19: 51–64—In this Article, the legend of figure 2A should state that there were 27 confirmed responses (rather than 28). In figure 4A, the first subheading in the inset on the graph should have referred to median progression-free survival in weeks, not months, and the second subheading in the inset on the graph should have read "6-month PFS, rate (95% CI)".

https://ift.tt/2Ki3Yny